TKL Clinical Research Organization Overview

TKL Research is an international clinical research organization (CRO) serving pharmaceutical, biotechnology, generic drug, OTC/consumer healthcare and medical device companies. TKL offers comprehensive services for designing, managing, monitoring and reporting on Phase 1–4 clinical research trials. TKL services are available for medical research studies in dermatology, endocrinology, metabolism, gastroenterology, pain management, respiratory, vaccines and infectious diseases.

TKL is the CRO that takes responsibility for enrollment. Through our deep understanding of investigators and site dynamics, we build solid relationships with site personnel who look to TKL for assistance with enrollment. TKL clients benefit with accelerated enrollment and reduced study timelines. Our experience enables us to understand the demographics of study participants in each therapeutic area and how to enroll them efficiently. TKL also understands how to identify high-enrolling sites and how best to work with them. Understanding both participant demographics and the site-selection process enables TKL to accelerate enrollment of high-quality study participants, usually with fewer sites.

TKL’s commitment to quality continues throughout the study. Senior-management oversight ensures that study challenges are anticipated and resolved proactively. Our project managers reduce the need for change orders through careful planning, oversight and tight budget control. Low staff turnover ensures continuity for your program. With an emphasis on communication and team building, we ensure that all project-team members are fully informed on study progress. In every study that we conduct, our process is aimed at developing a long-term relationship with your company.

To start your next clinical study with instant momentum, contact TKL, the CRO that takes responsibility for driving and accelerating enrollment.

Download our CRO Services brochure.